Skip to content

HB 269 · Pennsylvania · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
Pennsylvania
/
2025-2026
/
HB 269

Pennsylvania · 2025-2026 session · house

HB 269An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Status: Passed chamber
Latest action: 2025-04-28 — Referred to Health & Human Services
Primary sponsor: Arvind Venkat (Democratic)

Track this bill View changes+50 / −107 words · Large

Sponsors

Arvind Venkat (Democratic) · primaryprimary
Jamie Flick (Republican) · cosponsor

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy Pennsylvania bill RSS

Carol Hill-Evans (Democratic) · cosponsor

Tarik Khan (Democratic) · cosponsor

BSBenjamin Sanchez · cosponsor

Jim Haddock (Democratic) · cosponsor

Kyle Donahue (Democratic) · cosponsor

MSMichael Schlossberg · cosponsor

Steve Samuelson (Democratic) · cosponsor

JHJoseph Hohenstein · cosponsor

Joe Ciresi (Democratic) · cosponsor

PHPatrick Harkins · cosponsor

Versions

Printer's No. PN1331—
Printer's No. PN0214—

Legislative history

Apr 28, 2025
Referred to Health & Human Services
Apr 22, 2025
Re-reported as committed
Apr 22, 2025
Third consideration and final passage
Apr 9, 2025
Second consideration, with amendments
Apr 9, 2025
Re-committed to Appropriations
Apr 8, 2025
Removed from table
Mar 17, 2025
Reported as committed
Mar 17, 2025
First consideration
Mar 17, 2025
Laid on the table
Jan 22, 2025
Referred to Human Services

Official sources

Version 0PDF HTML DOCX
Version 1PDF HTML DOCX

House Fiscal NotePDF

About this page

Is this the official Pennsylvania bill page?: No — this is Billy’s public legislative record for HB 269. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track HB 269, get alerts, annotate diffs, and export Word work product.